Free Trial
LON:EDEN

Eden Research (EDEN) Share Price, News & Analysis

Eden Research logo
GBX 3.80
0.00 (0.00%)
(As of 11/1/2024 ET)

About Eden Research Stock (LON:EDEN)

Key Stats

Today's Range
3.80
3.90
50-Day Range
3.70
4.34
52-Week Range
3.61
7
Volume
199,062 shs
Average Volume
412,761 shs
Market Capitalization
£20.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides consumer products comprising head-lice treatment products, deodorants, odor neutralizers, fragrances, wound care products, food flavorings, and active ingredient supply/delivery products. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Receive EDEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eden Research and its competitors with MarketBeat's FREE daily newsletter.

EDEN Stock News Headlines

Banking failure dead ahead
If you missed it, my emergency election broadcast is now available - but will be removed soon
Spooky cocktail recipes for Halloween
See More Headlines

EDEN Stock Analysis - Frequently Asked Questions

Eden Research's stock was trading at GBX 5.75 at the beginning of the year. Since then, EDEN shares have decreased by 33.9% and is now trading at GBX 3.80.
View the best growth stocks for 2024 here
.

Eden Research plc (LON:EDEN) issued its earnings results on Tuesday, September, 29th. The company reported ($0.40) earnings per share for the quarter. Eden Research had a negative trailing twelve-month return on equity of 17.27% and a negative net margin of 38.70%.

Shares of EDEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Eden Research investors own include Kromek Group (KMK), Primary Health Properties (PHP), National Grid (NG.L), Cabot Energy (CAB), EPE Special Opportunities (ESO), Marston's (MARS) and Mothercare (MTC).

Company Calendar

Last Earnings
9/29/2020
Today
11/02/2024

Industry, Sector and Symbol

Industry
Agricultural Inputs
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
£-1,520,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.94 million
Cash Flow
GBX 0.32 per share
Book Value
GBX 2 per share

Miscellaneous

Free Float
N/A
Market Cap
£20.27 million
Optionable
Not Optionable
Beta
0.92
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (LON:EDEN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners